HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.

Abstract
The telomerase reverse transcriptase (TERT) promoter mutations are associated with increased TERT mRNA and TERT protein levels, telomerase activity, and shorter but stable telomere length. TERT promoter mutation is the most common mutation that occurs in approximately 60-80% of patients with bladder cancer. The TERT promoter mutations occur in a wide spectrum of urothelial lesions, including benign urothelial proliferation and tumor-like conditions, benign urothelial tumors, premalignant and putative precursor lesions, urothelial carcinoma and its variants, and nonurothelial malignancies. The prevalence and incidence of TERT promoter mutations in a total of 7259 cases from the urinary tract were systematically reviewed. Different platforms of TERT promoter mutation detection were presented. In this review, we also discussed the significance and clinical implications of TERT promoter mutation detection in urothelial tumorigenesis, surveillance and early detection, diagnosis, differential diagnosis, prognosis, prediction of treatment responses, and clinical outcome. Identification of TERT promoter mutations from urine or plasma cell-free DNA (liquid biopsy) will facilitate bladder cancer screening program and optimal clinical management. A better understanding of TERT promoter mutation and its pathway would open new therapeutic avenues for patients with bladder cancer.
AuthorsLiang Cheng, Shaobo Zhang, Mingsheng Wang, Antonio Lopez-Beltran
JournalHuman pathology (Hum Pathol) Vol. 133 Pg. 56-75 (03 2023) ISSN: 1532-8392 [Electronic] United States
PMID35700749 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2023 Elsevier Inc. All rights reserved.
Chemical References
  • Telomerase
  • TERT protein, human
Topics
  • Humans
  • Carcinoma, Transitional Cell (diagnosis, genetics, metabolism)
  • Mutation
  • Promoter Regions, Genetic (genetics, physiology)
  • Telomerase (genetics, metabolism)
  • Urinary Bladder (metabolism, pathology)
  • Urinary Bladder Neoplasms (diagnosis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: